Inhibition of tumor growth in vivo by a nanoparticle-based therapeutic cancer vaccine targeting HAAH

J Immunother Cancer · 2013 · PMC3991196

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

All three entities display highly significant, dose-dependent immunogenicity as assessed by antibody ELISAs.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.